ARMISTICE CAPITAL, LLC

Position in GSK — GSK plc

CIK 1601086 NEW YORK, NY

Position in GSK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$15,726,000

+$2,701,160 QoQ

Shares Held

300,000

+27.1% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#84

of 1,033 holders

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARMISTICE CAPITAL, LLC holds $110,331,379 across 6 Drug Manufacturers - General names. GSK ranks #3 (14.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SNY	Sanofi	1,064,000	$45,390,240
2	GRFS	Grifols SA	2,936,000	$20,786,880
3	GSK	GSK plc This page	300,000	$15,726,000
4	NVO	Novo Nordisk A S	312,000	$14,957,280
5	BMY	Bristol Myers Squibb Co	233,790	$13,470,979
6	MDCX	Medicus Pharma Ltd.	60,600	$0

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,726,000	300,000	+27.1%	Shares	Sole	2026-08-14
2026-03-31	$13,024,840	236,000	-76.4%	Shares	Sole	2026-05-15
2025-12-31	$49,040,000	1,000,000	+164.6%	Shares	Sole	2026-02-17
2025-03-31	$14,643,720	378,000	-84.1%	Shares	Sole	2025-05-15
2024-12-31	$80,423,960	2,378,000	+353.8%	Shares	Sole	2025-02-14
2024-09-30	$21,421,120	524,000	-65.1%	Shares	Sole	2024-11-14
2024-06-30	$57,750,000	1,500,000	+55.6%	Shares	Sole	2024-08-14
2024-03-31	$41,326,680	964,000	-56.1%	Shares	Sole	2024-05-15
2023-12-31	$81,383,760	2,196,000	+670.5%	Shares	Sole	2024-02-13
2023-09-30	$10,331,250	285,000	-5.0%	Shares	Sole	2023-11-14
2023-06-30	$10,692,000	300,000	-90.7%	Shares	Sole	2023-08-14
2023-03-31	$115,136,880	3,236,000	+5.9%	Shares	Sole	2023-05-15
2022-12-31	$107,387,840	3,056,000	-15.1%	Shares	Sole	2023-02-14
2022-09-30	$105,948,000	3,600,000	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.